It already has an existing weight-loss program that is on track to bring in more than $100 million in revenue by 2025, with the program selling oral weight-loss medications for about $79 per month
Once consistent supply is available through the pharmacies' wholesaler, Hims & Hers plans to make branded options available to customers, expanding the offering beyond the current oral medication kits and compounded GLP-1 injectable medications
Nakamaru Y, Akahoshi F, Iijima H, Hisanaga N, Kume T
You can also see people with normal BMIs potentially unhealthy and might have cholesterol-filled arteries and be at risk for cardiovascular disease, like heart attack or stroke
Thats how GLP-1s entered the weight loss conversation
Some people may switch or combine treatments under medical supervision